Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective

Abstract: Siu et al. comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications. The current situation in Canada is compared… Read More »